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ABSTRACT
Posttranscriptional RNA modifications occur in all
domains of life. Modifications of anticodon bases
are of particular importance for ribosomal decoding
and proteome homeostasis. The Elongator complex
modifies uridines in the wobble position and is highly
conserved in eukaryotes. Despite recent insights into
Elongator’s architecture, the structure and function
of its regulatory factor Kti12 have remained elusive.
Here, we present the crystal structure of Kti12′s nu-
cleotide hydrolase domain trapped in a transition
state of ATP hydrolysis. The structure reveals strik-
ing similarities to an O-phosphoseryl-tRNA kinase
involved in the selenocysteine pathway. Both pro-
teins employ similar mechanisms of tRNA binding
and show tRNASec-dependent ATPase activity. In ad-
dition, we demonstrate that Kti12 binds directly to
Elongator and that ATP hydrolysis is crucial for Elon-
gator to maintain proper tRNA anticodon modifica-
tion levels in vivo. In summary, our data reveal a
hitherto uncharacterized link between two transla-
tional control pathways that regulate selenocysteine
incorporation and affect ribosomal tRNA selection
via specific tRNA modifications.
INTRODUCTION
The eukaryotic Elongator complex (Elp1-Elp6) was origi-
nally isolated from yeast in association with actively tran-
scribing RNA polymerase II (1) and hence implicated in
transcription elongation (2). However, to date a robust
body of scientific evidence indicates that the major, if
not genuine, role of Elongator lies with its tRNA mod-
ification activity (3–5). Accordingly, Elongator binds tR-
NAs with different subunits (6–8) and constitutes the cen-
tral element of a conserved tRNA modification pathway
that is functionally exchangeable between eukaryotic or-
ganisms (4,5,9). In detail, the Elongator complex attaches
carboxymethyl (cm5) groups to uridine bases located in
the wobble position (U34) of tRNA anticodons. This piv-
otal substitution can be further converted to 5-carbamoyl-
methyl (ncm5), 5-methoxy-carbamoyl-methyl (mcm5) or
5-methoxy-carbamoyl-methyl-2-thio (mcm5s2) uridines by
other modification cascades (4,10).
Physiologically, the modified wobble uridines ensure effi-
cient tRNA selection in the ribosomal A-site (11,12), pro-
mote proper anticodon–codon interaction and guarantee
reading frame maintenance during mRNA translation (13–
15). Elongator inactivation by mutations or subunit dele-
tion lead to pleiotropic phenotypes (16) due to improper
translation (17), altered co-translational folding dynamics
(18) and disturbed proteome homeostasis (11,19). Further-
more, altered U34 modification levels are found in animal
disease models (20–22) as well as in patients suffering from
certain forms of cancer (23–26) and different neurodegen-
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erative diseases (27–29), thus reinforcing the importance of
Elongator for cell survival and proliferation control.
Hence, one might expect that Elongator is constitutively
active to ensure proper protein synthesis rates at all times.
Nevertheless, recent studies in yeast show that U34 modi-
fication levels do in fact oscillate during the cell cycle and
in response to varying environmental conditions (30–34).
Moreover, genetic screens (35,36) helped identifying acces-
sory proteins, which transiently interact with Elongator and
are as important for U34 modifications as the core Elonga-
tor complex itself (37–39). In particular, an isoform of the
casein kinase 1 (also known as Hrr25 or Kti14), the Sit4
protein phosphatase as well as Kluyveromyces lactis Toxin
Insensitive 12 (Kti12), were shown to affect the phosphory-
lation pattern of Elongator (40–42). Specific phosphoryla-
tion sites in Elp1 are critical for proper tRNA modification
activity and the recruitment of Hrr25 and Kti12 to Elon-
gator (25,40). Thus, the activity of Elongator appears to
be dynamically regulated by a complicated equilibrium of
phosphorylation and de-phosphorylation events.
Sequence similarities suggest that Kti12 shares a com-
mon ancestor with O-phosphoseryl-tRNA kinase (PSTK),
which in archaea and many eukaryotes is required for syn-
thesis of tRNASec and incorporation of selenocysteine (Sec)
into selenoproteins (43,44). Sec, the 21st naturally occur-
ring amino acid, lacks its own specific tRNA synthetase
and is not directly encoded by the standard genetic code.
Instead, the translating ribosome specifically incorporates
Sec after recognizing ‘selenocysteine insertion sequences’ in
the mRNA using tRNASec at recoded UGA stop codons.
The respective tRNASec is initially charged with serine
(tRNA[Ser]Sec) by seryl-tRNA synthetase (SerRS), phospho-
rylated by PSTK (tRNA[Sep]Sec) and finally converted to se-
lenocysteine tRNA (tRNA[Sec]Sec) by SecS synthetase (45–
47). PSTK specifically phosphorylates tRNA[Ser]Sec due to
its unique structure (48,49) and does not accept serine at-
tached to canonical tRNASer (44,45).
Here, we present the crystal structure of the N-
terminal domain of Kti12 fromChaetomium thermophilium
(CtKti12NTD) in complex with ADP·AlF3 and demonstrate
that Kti12 binds to tRNAs in a PSTK-like fashion. Strik-
ingly, the ATPase activity of Kti12 is tRNA dependent,
specifically induced by tRNASec and requires the 3′CCA
maturation signal. Structure-guided mutations within the
catalytic cavity and tRNA interaction surfaces of Kti12 val-
idate our comprehensive model of Kti12 and reveal that its
ATPase activity is essential for anticodon modification by
the Elongator complex. In summary, we identify yet un-
characterized similarities between two translational control
pathways that regulate the synthesis of selenoproteins and
translation elongation via cm5U modifications in the wob-
ble base position.
MATERIALS AND METHODS
Protein expression and purification
Genes encoding Kti12 proteins from Saccharomyces cere-
visiae (ScKti12) andC. thermophilum (CtKti12) were cloned
into pETM24d vector, which adds a C-terminal 6x-His tag
to the protein of interest. Proteins were expressed in the Es-
cherichia coli pRARE strain at 18◦C using overnight induc-
tion with 1 mM IPTG. Bacterial cells expressing Kti12 pro-
tein were suspended in an ice-cold 50 mM Tris–HCl pH 7.5
buffer containing 300 mM NaCl, 10 mM imidazole, 2 mM
DTT, 2 mM MgCl2 and a cocktail of protease inhibitors.
After addition of lysozyme and DNAse the suspension was
sonicated to homogeneity and centrifuged for 30 min at 87
000 g. The supernatant obtained was next subjected to se-
quential Kti12 purification at 4◦C on NiNTA (Qiagen), Hi-
Trap Q (GEHealthcare) and Superdex 200 10/300 GL (GE
Healthcare) columns. In all cases, the purification protocol
yielded protein samples close to homogeneity. The ScKti12
fusion construct (ScKti12-5x[GS]–first WD40-6xHis) was
purified similarly to ScKti12 WT protein. Use of a Hi-
Trap Heparin column (GE Healthcare) after the HiTrap Q
step yielded a homogenous protein sample that was sub-
sequently refined on a Superdex 200 column. Full length
Elp1 protein and its domains were expressed in Escherichia
coli pRARE strain from a pETM30 expression vector that
introduces an N-terminal 6xHis-GST tag followed by a
TEV cleavage site. The bacterial pellet was resuspended
in an identical buffer without imidazole and lysed using a
High Pressure Homogenizer Emulsiflex C3 (Avestin). Af-
ter centrifugation supernatant was circled overnight on a
GSTPrep FF 16/10 (GE Healthcare) column. The column
was washed with lysis buffer and protein was eluted using
a buffer that additionally contained 18 mM glutathione.
Overnight dialysis in the presence of GST-TEV protease
resulted in tag cleavage. GST tag and GST-TEV were re-
moved from the solution during subsequent rebinding to
the GSTPrep column. Both tagged and tag-free versions of
Elp1 were further purified on Superdex 200 10/300 GL col-
umn (GE Healthcare).
Crystallization and data collection
Homogeneous samples of CtKti12NTD were concentrated
and mixed with 3 mM ADP, 6 mM AlCl3 and 60 mMNaF
to a final protein concentration of 45 mg/ml. The crystals
were obtained after 3 days using the sitting-drop vapor dif-
fusion method. Mother liquor contained 100 mM MMT
buffer (DL-malic acid,MESmonohydrate, TRIS at pH 5.5)
and 25% (w/v) PEG1500. Harvested crystals were cryo-
protected in an identical solution containing 30% (v/v) glyc-
erol. For experimental phase determination, a JBS Magic
Triangle® (50) (Jena Bioscience) compound was added to
the cryo-protectant. X-ray diffraction data were collected at
MX-14-2 at BESSY II synchrotron source in Berlin, Ger-
many.
Structure determination and refinement
The crystal structure of CtKti12NTD•ADP/AlF3/Mg2+
was solved by the SAD method using crystals soaked with
JBS Magic Triangle. Native and phasing datasets were pro-
cessed with XDS package (51). An anomalous difference
map revealed the positions of six iodine atoms in the vicinity
of protein. Shelx, Resolve and Phaser software (52–54) were
used during initial phase determination and initial density
modification steps. The Coot program (55) was used for
manual building of a model that suits the obtained electron
density map. Preliminary structures were refined against
diffraction data using PHENIX software (54).
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Visualization of protein structure and bioinformatics
Sequence alignments were performed using Jalview soft-
ware (56). Molecules were visualized using PyMol soft-
ware (57). Protein conservation was analyzed using Con-
Surf server (58). Electrostatic potential of the protein sur-
face was estimated using APBS (59).
Mutagenesis and expression of Kti12 mutants
The QuickChange approach was used to perform an ala-
nine screening of several positions within CtKti12, namely
K14, T15, T16,D77, R84,K106/R109,D129Y,Y133/I134,
K135, Y139, R171, Y202, E203, R213, R222/W223,W232.
Corresponding residues in ScKti12 were identified using
multiple sequence alignment and homolog-based mod-
elling information, namely K14, T15, T16, D45, H52,
R62/R65, D85, Y89/I90, K91, Y95, K125, W132, E133,
R143, R152/W153 andW123 respectively. All CtKti12 pro-
tein mutants were purified using standard purification pro-
tocols described above for the wild type (WT) protein.
In vitro transcription of tRNA
Single tRNA species used herein were transcribed by T7
RNA polymerase from a linearized pUC19 vector harbor-
ing the corresponding tRNA genes under T7 promoter con-
trol. In vitro transcribed tRNA species were subsequently
purified on HiTrap DEAE FF columns (GE Healthcare)
and precipitated overnight in isopropanol. After removal of
supernatant, tRNAswere annealed by gradual cooling from
80◦C to 40◦C at a speed of 0.5◦C/min in the presence of an-
nealing buffer composed of 200 mM HEPES pH 7.5, 500
mM NaCl and 500 mM KCl. Next, the mixtures were en-
richedwith 1mMMgCl2 and 1mMDTTand tRNAspecies
were additionally purified by size-exclusion chromatogra-
phy on Superdex 75 10/300 GL column.
Measurement of Kti12 nucleotide binding affinity
Parameters of nucleotide binding byCtKti12 were dissected
using MANT-labeled (2′/3′-O-(N-Methyl-anthraniloyl),
Jena Bioscience) ATP or its non-hydrolysable analog,
AMPPNP (adenosine-5′-[(, )-imido] triphosphate). 4
M protein was titrated with two-fold serial dilutions
of MANT-labeled nucleotide. MANT concentrations
ranged from 100 M to 50 nM and the final volume of the
mixture was 100 l. Affinity to the ATP and AMPPNP
in the presence of tRNASec was determined using only 1
M CtKti12 protein and 1 M tRNASec. In experiments
involving tRNASec and CtKti12NTD/CTD three-fold serial
dilutions covered a range between 15 M and 61 nM.
Protein was incubated with a nucleotide and incubated
for 30 min at 37◦C, then the mixture was transferred to a
96-well, black, flat-bottom, chimney-well microplate and
incubated for additional 2 min inside of the preheated to
37◦C SpectraMAX GeminiEM plate reader (Molecular
Devices). FRET was induced using ex: 280 nm incident
light, MANT fluorescence was measured at em: 448
nm. Data for protein (ex: 280 nm; em: 340 nm) and
fluorophore (ex: 340 nm; em: 448 nm) fluorescence were
also collected as a control of protein and fluorophore
amount. FRET (ex: 280 nm; em: 448 nm) values after
subtraction of respective protein-free controls are shown,
all experiments were conducted in triplicates.
Measurement of Kti12 enzymatic activity
Nucleotide hydrolysis capacity of Kti12 proteins was in-
vestigated using the Malachite Green Phosphate Assay Kit
(SigmaAldrich). Reactions were performed in a buffer com-
posed of 20 mM Tris–HCl, 150 mM NaCl, 2 mM DTT,
2 mM MgCl2 and 900 M nucleotide. Final protein and
tRNA concentrations were adjusted to 1 M. In case of
reactions conducted in the presence of Elongator subunit
Elp1, the protein was added to the reaction mixture at in-
dicated molar ratios. Assembled reactions were incubated
for 15 hours at 37◦C. After incubation, the reaction mix-
tures were diluted 10 times in water and the phosphate con-
centrations were measured according to a standard absorp-
tion protocol at  = 620 nm. The data are presented as
the mean ± standard deviation of three independent exper-
iments with at least 2 technical replicas each.
Thermal shift assay
The thermostability of Kti12 proteins was assessed us-
ing thermal shift assays in the presence or absence of nu-
cleotides. In each case, 7 g of protein was incubated in
20 mM Tris–HCl pH 7.5, 150 mM NaCl, 2 mM DTT, 2
mMMgCl2 with the addition of 1 mM nucleotide. Temper-
ature gradients spanned from 4◦C to 98◦C. Samples were
heated at a speed of 0.6◦C/min in presence of SYPRO
Orange (Sigma Aldrich) hydrophobic fluorescent dye. Pre-
sented data derive from three independent experiments with
at least 2 technical replicas each.
Yeast genetic manipulations
S. cerevisiae strains containing mutated kti12 alleles were
generated and are listed in Supplementary Table S1. The
parent strain for generation and expression of HA-tagged
Kti12 point mutants was YAH76, which has the KTI12
coding sequence replaced by the marker gene KlURA3
(kti12Δ::KlURA3) (60) and allows for expression of c-myc-
tagged Elongator subunit Elp1 [ELP1-(c-myc)3]. YAH76
is congenic with UMY2893 (4), which contains the SUP4
tRNA suppressor allele and the SUP4 suppressible ade2–1
and can1–100 reporters. Mutant strains mentioned in Sup-
plementary Table S1 were generated by site-directed muta-
genesis (61) on genomic DNA from strain YAH3 (KTI12-
(HA)6::KlTRP1) to enable simultaneous HA-tagging.
The kti12-mutated PCR fragments were transformed into
YAH76 (62), and transformants were selected for trypto-
phan prototrophy and loss of the KlURA3 marker on the
basis of 5-fluoroorotic acid resistance. Correct replacement
of theKlURA3-knockout cassette by the mutagenized kti12
alleles was diagnosed by PCR, and all mutations were veri-
fied by DNA sequencing.
Bulk yeast tRNA isolation
Saccharomyces cerevisiae strains were grown in YPD to an
OD600 ∼1, harvested and washed once with water, then di-
rectly subjected to tRNA isolation using RotiZOL reagent
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(Carl Roth, Germany) according to the manufacturer’s in-
struction. Large RNAs were precipitated for 3 h at –20◦C
with 1/3 vol. of 8 M LiCl. Small RNAs in the supernatant
were precipitated with 1/10 volume of 3 M sodium acetate
pH 5.2 and 2.5 volumes 100% ethanol for 60 min at –80◦C.
The pellet was washed twice with 75% ethanol, then air
dried and resuspended in 10 mM sodium acetate pH 5.2, to
prevent deacylation of aminoacylated tRNAs as described
by Ko¨hrer and Rajbhandary (63).
Measurement of CtKti12 binding affinity to tRNA by EMSA
Binding of CtKti12 to S. cerevisiae WT bulk yeast tRNA
(ytRNA) was analysed by electrophoretic mobility shift as-
says (EMSA). The binding reactions were performed in 4
l binding buffer (20 mM Tris–HCl pH 7.5 at RT, 150 mM
NaCl, 2 mMDTT, 1 mMMgCl2), containing 25 ng ytRNA
and 1.25, 2.5 or 5 M CtKti12 (WT or annotated mu-
tant CtKti12 full length (FL), NTD or CTD fragments).
For dissociation constant (KD) estimation of WT CtKti12-
FL to ytRNA, 4 l binding buffer containing 6.25 ng or
12.5 ng ytRNA (∼0.055 or 0.11 M, respectively) and 0.06,
0.125, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, 2.5 3.0, 4.0, 5.0
and 7.5 M ChKti12-FL were mixed. After 30 min incu-
bation at RT, 1 l 50% sucrose (v/v) was added to the re-
actions and they were loaded on a 5% polyacrylamide gel
containing TB-Buffer (45 mM Tris–HCl pH 7.0 at 4◦C, 45
mM boric acid) and 10% sucrose. Electrophoresis was per-
formed in TB buffer for 90min and 60 V at 4◦C. The gel was
stained with SYBR Gold (Thermo Fisher Scientific) for 20
min and visualized on an UV table at 306 nm. Analysis of
bound and free tRNA bands by densitometry was carried
out using ImageJ2 (64) from three replicate experiments.
The tRNAbound/tRNAtotal ratios were calculated, plotted
against log10 [CtKti12-FL] and used to estimate the KD for
the interaction by sigmoidal dose response fitting (Graph-
Pad Prism version 6.01 for Windows, GraphPad Software,
La Jolla, CA, USA).
Yeast protein extraction, co-immunoprecipitation and West-
ern blot analysis
Yeast cells from 100 ml liquid cultures were harvested at an
OD600 ∼ 1 and resuspended in 800l ice-cold B60 buffer (50
mM HEPES–KOH pH 7.3, 60 mM KAc, 5 mM Mg(Ac)2,
0.1% Triton X-100, 10% glycerol, 1 mM NaF, 20 mM -
glycerophosphate, 1 mM DTT) supplemented with Com-
plete protease inhibitor cocktail (Roche,Germany). Follow-
ing addition of 600 l glass beads, cell disruption was car-
ried out at 4◦C by vigorously shaking (5× for 1 min). Cell
debris was removed by centrifugation at 15 000 rpm and
4◦C for 5 min. An additional clearing step of the super-
natant was performed at 15 000 rpm and 4◦C for 20 min.
Protein concentration of cleared lysates was determined
using Protein Assay Dye reagent (Bio-Rad, USA). Co-
immunoprecipitation was done on the cleared lysate, using
either anti-c-myc (9E10, Santa Cruz Biotechnology, USA)
or anti-HA (F-7, SantaCruzBiotechnology,USA) antibod-
ies coupled to magnetic Dynabeads (Invitrogen, USA) ac-
cording to manufacturer’s instructions. 2 mg lysate was in-
cubated with 2 g antibody-coupled Dynabeads for 60 min
with end-over rotation at 4◦C. Antibody bound fractions
were collected using a magnetic rack and washed 3× with
B60 buffer. Proteins were eluted from the beads by addi-
tion of 50 l 1× Laemmli sample buffer (65) and incubat-
ing at 99◦C for 10 min. Control samples prior to immuno-
precipitation (Pre-IP) were taken from lysates before addi-
tion of antibody-coupled Dynabeads and boiled at 99◦C for
10 min in 1× Laemmli sample buffer. Protein samples were
separated by SDS-PAGE and analyzed by Western blotting
using anti-c-myc (9E10, Thermo Fisher Scientific, USA),
anti-HA (Ab-1, Dianova, Germany) and anti-Cdc19 serum
(kindly provided by Dr J. Thorner, University of California,
Berkley, CA, USA).
GST pull down assay
Equimolar amounts of ScKti12 and GST-ScElp1 were in-
cubated on a rotating wheel in the presence of Glutathione
Sepharose 4B (GE Healthcare) for 2 h at 4◦C in a buffer
composed of 20 mM Tris–HCl pH 7.5, 150 mM NaCl, 2
mM DTT, 2 mM MgCl2, 0,5% (v/v) Tween 20. Pure GST
protein was used as a specificity control. Glutathione beads
were collected by gentle spinning (500 × g) and subse-
quently washed three times with a binding buffer. Bound
proteins were denatured at 95◦C in the presence of Laemmli
sample buffer and analyzed on 12% SDS-PAGE.
Phenotypic analyses of yeast mutants using assays indicative
for U34 modification defects
To analyze the function of mutated kti12 alleles in tRNA
modification by Elongator, sensitivity of yeast strains to-
wards growth inhibition by exogenous zymocin toxin com-
plex or intracellular expression of zymocin’s  -toxin tR-
Nase subunit was assayed as previously described (66).
Zymocin was partially purified from supernatants of
Kluyveromyces lactis killer strain AWJ137 (66) by ultrafil-
tration (67). Strains were spotted in ten-fold serial dilution
on synthetic drop-out (SD) media plates (pH 7.0) or on rich
media plates (YPD, 0.5% yeast extract, 2% peptone, 2% glu-
cose and 2% agar) containing zymocin (2–10% v/v) and in-
cubated for 2–3 days at 30◦C. To test the effect of intracellu-
lar expression of zymocin’s  -toxin tRNase subunit on cell
growth, strains were transformed with vector pLF16, which
expresses the  -toxin gene from the galactose-inducible
GAL1 promoter (68). To monitor the response to  -toxin
induction, transformed strains were spotted in ten-fold se-
rial dilution on synthetic drop-out media plates (SD) con-
taining either 2% glucose (repressing conditions) or 2%
galactose (inducing conditions) and incubated for 3 days
at 30◦C. Kti12 and Elongator dependent U34 modifications
confer growth inhibition by the tRNase activity of zymocin
whereas defects in Kti12 and Elongator cause resistance to
the toxin complex (66). Analysis of the effect of kti12 mu-
tations on ochre (UAA) stop-codon read-through by the
Elongator-dependent suppressor tRNA SUP4 was essen-
tially as described (4). Yeast strains based on UMY2893
(ade2–1 can1–100; Supplementary Table S1) were spotted
on SD plates lacking adenine (–Ade) or medium without
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arginine but containing the toxic arginine analog canava-
nine. Plateswere incubated for 4 d at 30◦C.TheSUP4 tRNA
is non-functional in cells that lack Kti12 activity or Elonga-
tor dependent U34 modifications, and thus does not allow
for growth in the absence of adenine but confers resistance
to growth inhibition by canavanine (4).
Relative quantitation of tRNA wobble uridine modifications
by LC–MS/MS analysis
Total tRNA was isolated from yeast cultures as described
previously (5). Prior to LC–MS/MS analysis, 5 g of each
tRNA sample were digested into nucleosides according to
the following protocol: samples were incubated in the pres-
ence of 5 mM ammonium acetate (pH 5.3), 0.3 U nucle-
ase P1 (both Sigma Aldrich, Munich, Germany) and 0.1 U
snake venom phosphodiesterase (Worthington, Lakewood,
USA) at 37◦C for 2 h. Next, 1/10 volume of 100 mM am-
monium acetate (pH 8) and 1 U fast alkaline phosphatase
(Thermo Scientific, Waltham, MA, USA) were added, and
samples were incubated for additional 60 min at 37◦C. The
digested tRNA samples were analyzed on an Agilent 1260
HPLC series equipped with a diode array detector (DAD)
and a triple quadrupole mass spectrometer (Agilent 6460).
A Synergy Fusion RP column (4 m particle size, 80 A˚
pore size, 250 mm length, 2 mm inner diameter) from Phe-
nomenex (Aschaffenburg, Germany) was used at 35◦C col-
umn temperature. The solvents consisted of 5 mM ammo-
nium acetate buffer adjusted to pH 5.3 using acetic acid
(solvent A) and pure acetonitrile (solvent B). The elution
was performed at a flow rate of 0.35 ml/min using a lin-
ear gradient from 0% to 8% solvent B at 10 min, 40% sol-
vent B at 20 min and 0% solvent B at 23 min. For an ad-
ditional 7 min, the column was rinsed with 100% solvent
A to restore the initial conditions. Prior to entering the
mass spectrometer, the effluent from the column was mea-
sured photometrically at 254 nm by the DAD for the detec-
tion of the four canonical nucleosides. The triple quadru-
ple mass spectrometer, equipped with an electrospray ion
source (Agilent Jet Stream), was run at the following ESI
parameters: gas (N2) temperature 350◦C, gas (N2) flow 8
l/min, nebulizer pressure 50 psi, sheath gas (N2) temper-
ature 350◦C, sheath gas (N2) flow 12 l/min and capillary
voltage 3000 V. The MS was operated in the positive ion
mode using AgilentMassHunter software andmodified nu-
cleosides were monitored by multiple reaction monitoring
(dynamic MRM mode). For identification of s2U and re-
tention time determination, comparison to a synthetic stan-
dard (Berry & Associates, Dexter, USA) was used. Identi-
fication of ncm5U, mcm5U and mcm5s2U peaks were per-
formed as described previously (69). All mass transitions
and retention times used for identification of the modified
nucleosides are listed in Supplementary Table S2. Peak ar-
eas were determined employing Agilent MassHunter Qual-
itative Analysis Software. In the case of the major nucle-
osides, peak areas were extracted from the recorded UV
chromatograms in order to avoid saturation of the mass sig-
nals. For intersample comparability of the detected modi-
fications, the peak areas of the modified nucleosides were
normalized to the UV peak area of uridine.
RESULTS
The structure of Kti12 resembles PSTK
The highly conserved eukaryotic Kti12 proteins can be di-
vided into two separate domains, which are connected by a
flexible linker region. The N-terminal domain (NTD) har-
bors a typical ATPase signature, but the C-terminal do-
main (CTD) has no assigned enzymatic or functional mo-
tif (Figure 1A). Kti12 shares high sequence similarity and
domain architecture with PSTK (43,70,71). We were able
to express and produce large quantities of full length and
truncated versions of Kti12 from Saccharomyces cerevisiae
(ScKti12) and C. thermophilum (CtKti12; Supplementary
Figure S1A). Purified Kti12 protein samples were used
in co-crystallization experiments in the presence and ab-
sence of various ATP analogs. We obtained well diffracting
crystals of CtKti12NTD (aa2–252) after addition of magne-
sium, ADP and aluminum fluoride (ADP·AlF3; (72)). The
crystal structure of CtKti12NTD was solved in the P3121
space group using single wavelength anomalous diffraction
(SAD) phasing (Figure 1A). Six individual iodine atoms
could be located within the asymmetric unit belonging to
two bound ‘magic triangle‘ molecules that had been soaked
into existing crystals (Supplementary Figure S1B). Using a
native dataset at 2.4 A˚, a final atomic model was built and
refined to R/Rfree values of 23.9/27.5% (Table 1) obeying
perfect stereochemistry.
The structure shows a globular ATPase domain that con-
sists of five parallel -sheets and eight -helices surround-
ing the hydrophobic core of the domain (Supplementary
Figure S1C). Except for two flexible loop regions, that are
not conserved and only exist in CtKti12, all residues are
clearly visible and traceable in the density. As previously
predicted (73), Kti12NTD indeed harbors a canonical P-
loop motif, located between the first strand (1) and the
first helix (1). The superimposition of CtKti12NTD with
known structures of full length Methanocaldococcus jan-
naschii PSTK (MjPSTK; PDB IDs 3ADB and 3A4L) re-
vealed very strong structural similarities (Figure 1B). Fur-
thermore, likeness between Kti12 and PSTK spans beyond
the NTD as both proteins display a short linker region fol-
lowed by a conserved CTD that is composed of three pre-
dicted helices (Supplementary Figure S2A).
As the CTD of PSTK binds to tRNA[Ser]Sec (74), we
tested whether Kti12 is able to bind to endogenous bulk
tRNAs and uses a similar mechanism for tRNA recogni-
tion. CtKti12 indeed binds tRNAs mainly via its CTD in
an almost identical fashion as PSTK (Figure 1C). The affin-
ity constants (KD ∼1.5 M) are typical for proteins bind-
ing transiently to tRNAs (6,75). As Kti12 shifted the entire
population of yeast bulk tRNAs (Supplementary Figure
S2B,C) and bound with similar affinities to different in vitro
transcribed tRNAs (Supplementary Figure S2D) it does not
seem to prefer or select any particular tRNA species at the
initial binding step. Kti12 does not share any larger protein-
protein interfaces with neighboring molecules in crystals
and full length and truncated forms of CtKti12 or ScKti12
eluted as a single monomeric peak from the gel filtration
columns (Supplementary Figure S1A). Therefore, we as-
sume that unlike PSTK, which has been previously reported
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Figure 1. Kti12 resembles PSTK both structurally and functionally. (A) Structure of a CtKti12NTD locked in a transition state of ATP hydrolysis shown
in a cartoon representation. Aluminum fluoride, a hydrolysis transition state mimetic (magenta and cyan) and magnesium (green sphere) are highlighted.
The protein core consists of a single -sheet composed of five parallel -strands (dark blue). Domain architectures of CtKti12 and ScKti12 are similar
to that of MjPSTK. ATPase motifs located on the N-terminal domain (NTD) of Kti12 (blue) and PSTK (red); C-terminal domain (CTD; yellow). (B)
Structure of CtKti12NTD (blue) resembles the one of MjPSTKNTD bound to tRNASec (red; PDB ID 3ADB). The 3′ CCA of tRNASec is inserted into the
PSTKNTD while the tRNA body is mainly held by PSTKCTD (yellow). The anticodon region (green) is not involved in this interaction. C. Binding affinity
of CtKti12 with bulk yeast tRNAwas examined by electrophoretic mobility shift assay (EMSA) using 5% native PAGE. Free tRNA and tRNA in complex
with CtKti12-FL or CtKti12CTD were visualized using SYBR-Gold. Both full-length (FL) protein and CtKti12CTD bind tRNA in a PSTK-like fashion.
Table 1. Data collection and refinement statistics
Ct Kti12 1–254 Ct Kti12 1–254 (phasing)
PDB ID 6QP0 -
Data collection
Beam line BESSY II, MX14–2 BESSY II, MX14–2
Wave length (A˚) 0.982 1.645
Space group P31 2 1 P31 2 1
Cell dimensions (A˚) 71.02 71.02 88.57 90 90 120 72.21 72.21 89.20 90 90 120
Resolution (A˚)a,b 50–2.4 (2.48–2.4) 50–2.1 (2.15–2.1)
Unique reflections 10 334 (723) 29 320 (2087)
Completeness (%) 99.5 (95.0) 96.1 (92.0)
Redundancy 7.9 (4.8) 20.7 (20.4)
Rsym 0.15 (0.886) 0.15 (3.06)
I/(I) 12.3 (1.98) 14.97 (1.02)
Iodine atoms per ASU 0 6
Structure refinement
Working set reflections 10 300
Test set reflections 517
Resolution (A˚) 35.5–2.4
Number of protein atoms 1526
Number of ligand 44
Number of solvent molecules 46
Rwork/Rfree 0.239/0.275
Average B factor (A˚2)
Overall 49.9
Protein 50.1
Ligand 55.3
Solvent 36.7
RMSD values
Bond lengths (A˚) 0.0017
Bond angles (◦) 0.61
Ramachandran-plot analysis
Most favored regions (%) 96.67
Allowed regions (%) 3.33
Disallowed regions (%) 0
aValues in parentheses are for the highest-resolution shell.
bResolution limits according to an I/ of 2 are 2.7 A˚ for the native ChKti12 dataset.
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to form dimers (70,74,76), Kti12 stays monomeric in solu-
tion.
The active site of Kti12 resembles a canonical ATPase
We solved the structure of CtKti12NTD in complex with
ADP·AlF3 mimicking a bi-pyramidal transition state dur-
ing ATP hydrolysis (77). The ADP·AlF3 molecule as well
as the expected magnesium ion are clearly visible in the
electron density. The nucleotide binding pocket of CtKti12
utilizes the evolutionarily conserved architecture typical of
canonical P-loop ATPases (Figure 2A). In detail, several
conserved residues, namely K14, T15, T16, D129 and R171
interact with the first two phosphate atoms (P and P).
D77,R84,Y202 are in close contact with theAlF3 molecule,
which mimics the third phosphate (P ) and shows a typi-
cal distance for a transition state of 3.0 A˚ from the P. The
addition of ATP contributed to an increased thermosta-
bility of CtKti12 and ScKti12 in vitro. ADP, ADP·AlF3
and AMPPNP, a non-hydrolysable ATP analog, however
had no significant effects on melting temperatures (Figure
2B). Thermal shifts after addition of ATP and in the ab-
sence of tRNA show a similar stabilization of both the full-
length proteins and the truncatedNTDs alone (Supplemen-
tary Figure S3A). Therefore, we speculate that the observed
effects do not result from large conformation rearrange-
ments of the two domains but rather represent local com-
paction of the defined ATP binding site. Despite intense co-
crystallization trials, no analyzable crystals were obtained
in the presence of ATP or other nucleotides.
Enzymatic activity of Kti12 depends on tRNA binding
Surprisingly, none of the purified Kti12 proteins displayed
any basal ATPase activity in vitro (Figure 2B). To under-
stand the mechanism of Kti12 action, we asked whether
Kti12 might require a cofactor to activate its ATPase func-
tion. Therefore, Kti12 proteins were incubated with ATP
andmagnesium in the presence of bulk tRNAs from various
yeast strains or different purified in vitro transcribed tRNA
species containing CCA tails (e.g. tRNAGlu, tRNASer and
tRNASec). In analogy to PSTK, both ScKti12 and CtKti12
showed a significant upregulation of ATPase activity upon
treatment with in vitro transcribed tRNASec (Figure 2C and
Supplementary Figure S3B,C,D). The observed ATP hy-
drolysis rate ofKti12 in the presence of tRNASec (kcat = 1.59
× 10−3 s−1) is ∼100× faster than the activation rate of ar-
chaeal MjPSTK (70). As neither any of the other tRNA
samples, nor polyU RNA or the anticodon stem loop of
tRNASec induce the ATPase activity of Kti12, the underly-
ing mechanism seems highly specific (Figure 2C). Further-
more, we used MANT-labeled nucleotides to determine the
binding constants of ATP (KD ∼ 1.0 M) and AMPPNP
(KD ∼ 8.6 M) to ChKti12 (Figure 2D and Supplementary
Figure S3E). We did not observe any changes in affinity for
the nucleotides in the presence of tRNASec, showing that
tRNA does not boost the activity by increasing the rate of
ATP binding (Figure 2D).
A comparison between full length protein, NTD, CTD
and a stoichiometric mixture of NTD and CTD revealed
that both domains need to be connected within a single
polypeptide chain to induce ATP hydrolysis efficiently and
cannot be activated in trans (Figure 2D and Supplementary
Figure S3E). Our data also clearly shows that nucleotides
are bound only by the NTD and that the CTD does not
influence the affinity of the NTD to ATP (Figure 2D). No-
tably, Kti12 does not require tRNA to be charged with an
amino acid for ATPase activation, and fungi generally lack
important components of the selenocysteine biosynthesis
pathways (78). Although the rational for the observed speci-
ficity is not yet clear, we utilized human tRNASec to study
the enzymatic properties of Kti12 in greater detail.
Identification of catalytic residues in Kti12
To dissect the specific contribution of active site residues for
the catalytic reaction, we individually mutated all residues
in the vicinity of the bound ADP·AlF3 molecule (Fig-
ure 3A). Next, we analyzed the ATP hydrolysis rates,
thermostability profiles, ATP- and tRNA-binding capac-
ities of all substituted variants. As the introduction of
almost all equivalent mutations in ScKti12 led to in-
soluble proteins, our analyses in vitro focused on vari-
ants in CtKti12. Substituting the most central residue,
K14A, resulted in complete loss of ATPase activity in
vitro (Figure 3B). Other mutations, like T15A, R171A
and W232A, strongly decreased Kti12’s ATP hydrolysis
rates. D77A, Y202A and T16A/D129A show slightly de-
creased ATPase activity, whereas T16A, R84A and D129A
behave like wild type Kti12. Certain mutants displayed
decreased thermal stability profiles (e.g. T15A, D129A,
T15A/D129A, T16A/D129A and T16A/D129A) partially
explaining slightly decreased activities due to overall protein
destabilization (Supplementary Figure S4A). Interestingly,
the strong effect of K14A can be partially rescued by intro-
ducing D129A indicating a functional link between these
two residues. As D129A also shows a stimulatory effect in
combination with T15A (T15A/D129A) generating a hy-
peractive form of Kti12, D129 (D85 in ScKti12) might act
as a negative regulator and molecular switch during the cat-
alytic cycle. Strikingly, none of the ATPase mutants affects
tRNA binding affinities, indicating that although tRNA
binding is essential for ATPase activity, the rate of ATP hy-
drolysis does not affect tRNAbinding byKti12 in vitro (Fig-
ure 3C).
In CtKti12, the adenine base of ATP is mainly coordi-
nated by -stacking interactions with W232 (Figure 2A),
whereas archaeal PSTK employs arginine residues to co-
ordinate the nucleotide base. W232 is not conserved, but
in structural homology models of other Kti12 sequences, a
highly conserved tryptophan residue (e.g. ScKti12 W123)
located in the same position as the arginine in PSTK (he-
lix 4) could substitute (74). Notably, Kti12 shows a clear
preference towards ATP and only very weakly hydrolyzes
UTP, GTP or CTP (Supplementary Figure S4B). As PSTK
shows broad nucleotide hydrolysis activity (70), we specu-
late that the conserved tryptophan residue in Kti12 confers
selectivity for ATP. Notably, substitution of W232 with ala-
nine boosted the thermostability of CtKti12 (from 47◦C to
57◦C), but resulted in a lack of ATP-dependent stabiliza-
tion (Supplementary Figure S4C, D). Thus, we hypothe-
size that the thermal shifts observed after addition of ATP
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Figure 2. Structural and functional characterization of ATP hydrolysis by Kti12. (A) A structural close-up of the ATP-binding pocket with important
residues shown in ball-and-stick representation. Isomesh represents an OMIT map at  = 1.0 around the ligand. Aluminum fluoride (magenta and
cyan) and magnesium (green) are shown and the residues involved are labeled. (B) Thermal shift assays with ScKti12 (top) and CtKti12 (bottom) in
the presence/absence of nucleotides. ATP hydrolysis (bottom right) was investigated using the malachite green method (right). Yeast seryl-tRNA syn-
thetase was used as a positive control for basal ATP hydrolysis relative to ATP alone. (C) ATP hydrolysis of ScKti12 and CtKti12 in response to bulk or in
vitro transcribed tRNAs (see labeling). All in vitro transcribed tRNAs possess 3′ CCA. Deamino-acylated (aa) tRNAwas obtained by deamino-acylation
of bulk tRNA obtained from WT yeast cells. A poly U (nine bases) and a tRNASec anticodon arm hairpin were used as a specificity control. Reactions
contained tRNA and protein mixed at 1:1 stoichiometry and were incubated for 15 hours at 37◦C. Results are presented as the percent of ATP hydrolyzed
and calculated standard deviations are shown (n = 3). (D) Similarly, to (C), tRNASec was used to induce ATP hydrolysis in FL proteins, NTDs, CTDs or
1:1 stoichiometric mixture of NTDs and CTDs and calculated standard deviations are shown (n = 3).
partially originate from reduced degrees of freedom for this
rather bulky residue. Foremost, all tested active site mutants
lead to a detectable decrease in affinity to ATP and reduced
ATP-dependent protein stabilization (Supplementary Fig-
ure S4C, D).
The NTD of Kti12 couples tRNA recognition with ATP bind-
ing and hydrolysis
Analyses of sequence conservation and charge distribu-
tion within Kti12NTD revealed an evolutionary conserved
and positively charged surface area (Supplementary Fig-
ure S5A–C). Structural modeling of tRNA-bound Kti12
complex based on the known MjPSTK structure in com-
plex with tRNASec (PDB ID: 3ADB) specifically positioned
the acceptor stem of the bound tRNA molecule next to the
aforementioned basic surface patch (Figure 4A). The ob-
tained structural model places the 3′CCA sequence poten-
tially carrying the charged amino acid in close proximity to
a channel leading directly to the ATPase site (Figure 4A).
Therefore, our model may be indicative for a Kti12 reaction
scheme that would be remarkably similar to that of PSTK.
To verify our hypothesis, we checked the ATPase activity
and tRNA binding properties of a number of Kti12 vari-
ants containing amino acid substitutions replacements lo-
cated in the anticipated Kti12-tRNA interface of the NTD
(Figure 4B).
In case of K106A/R109A, Y133A/I134A, K135A and
E203A, we observed a substantial decrease in tRNA-
induced ATPase activity. This strongly suggests the involve-
ment of these residues in tRNA binding and shows that
the predicted tRNA interaction surface area is mechanis-
tically coupled to the spatially separated ATPase site (Fig-
ure 4B). Strikingly, R213A not only has enhanced tRNA-
induced ATPase activity but also shows increased basal hy-
drolysis activity in the absence of tRNAs (Figure 4C). As
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Figure 3. Mutational analysis of the nucleotide binding pocket in CtKti12. (A) Two dimensional LigPlot (92) overview of the nucleotide binding pocket
and residues targeted for mutations. Mutants with abolished (K14A, red), decreased (orange) or normal (green) ATPase activity are highlighted. Potential
hydrogen bonds are shown as black dashed lines. Additionally, - stacking between adenine and W232 and a distance between the oxygen of phosphate
beta and aluminum is shown. (B) ATP hydrolysis by wild type and mutant forms of CtKti12 in response to tRNASec showing the calculated standard
deviations (n = 3). Mutants are labeled as in (A) and the upregulated combined mutant is shown in dark green. (C) Analysis of tRNA binding properties
in selected nucleotide binding pocket mutants by EMSA. Increasing concentrations of protein (1.25, 2.5 and 5 M) were incubated with 0.22 M yeast
bulk tRNA and resolved on a 5% native PAGE. tRNA was stained using SYBR-Gold. As a loading control, samples were also analyzed by denaturing
SDS-PAGE and stained with Coomassie (lower panel).
the location of R213 overlaps with the modeled 3′CCA se-
quence, we suspect it may act as a gatekeeper that has to
be displaced by the incoming tRNA for hydrolysis to oc-
cur. We also observed weak basal hydrolysis rates in case
of K135A, suggesting an involvement in correct position-
ing of the neighboring R213 residue. The most remote
substitutions, Y139A and R222A/W223A, did not affect
tRNA-induced ATPase activity (Figure 4B) or thermosta-
bility (Supplementary Figure S5D). The CTD of Kti12 is
the major tRNA binding site and if at all, the NTD by itself
has only very weak affinity for tRNAs (Figure 1C). There-
fore, we suspected that NTD mutations in the full-length
Kti12 protein (containing the CTD) may not necessarily af-
fect tRNAbinding.Nevertheless, certainmutations, namely
K106A/R109A, K135A and R222A/W223A, resulted in a
small but noticeable decrease in ATP- and tRNA-affinity
(Figure 4D and Supplementary Figure S5D), further sup-
porting the mechanistic role that the basic region identified
in Kti12NTD plays in tRNA binding and recognition.
Kti12 ATPase activity is crucial for Elongator’s tRNA mod-
ification activity in vivo
In order to better understand the in vivo role of Kti12 and
its ATPase activity, we analyzed yeast strains carrying mu-
tations in the nucleotide binding pocket of ScKti12 equiv-
alent to CtKti12 (Figure 3A). Firstly, we isolated bulk tR-
NAs from these strains and used mass spectrometry (LC–
MS/MS) to profile Elongator dependent tRNA modifica-
tions quantitatively. Strongly decreased levels of the U34
modification types ncm5U, mcm5U and mcm5s2U were
observed in kti12 cells and in kti12 mutants expressing
catalytically defective Kti12 proteins (Figure 3B), namely
K14A and T15A (Figure 5A). In addition, these mutants
accumulate s2U, an abnormal thio-modification not de-
tected in tRNAs from the KTI12 wild-type strain or the
T16Amutant (Figure 5A) and typical of Elongator mutants
(4,79) when full U34 modifications cannot be accomplished.
In case of T16A, D85A (analogous to D129A in CtKti12)
and D85A/T15A, with intact ATPase activity (Figure 3B),
the ncm5U, mcm5U and mcm5s2U modifications were de-
tectable albeit at moderately lowered levels compared to the
wild-type (Figure 5A).
We tested all kti12mutants by previously established phe-
notypical surveys (zymocin,  -toxin and SUP4 assays) di-
agnostic for Elongator’s tRNAmodification function in vivo
(4,66). The zymocin and  -toxin assays are based on a fun-
gal anticodon nuclease which cleaves mcm5s2U34 modified
tRNAs and thereby inhibits yeast growth in an Elongator
dependent fashion (68,80). Thus, extracellular application
of the zymocin complex (zymocin assay) or conditional ex-
pression of its tRNase  -toxin subunit ( -toxin assay) allow
to monitor the U34 modification states of Elongator sub-
strate tRNAs based on toxin sensitivity or resistance phe-
notypes (see method section) (81). As expected, elp3 and
kti12 mutants were found to resist against zymocin and
 -toxin (Figure 5B) confirming the importance of Kti12
for Elongator function (66). The ATPase defective mutants
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Figure 4. Analysis of tRNASec interaction with CtKti12NTD. (A) (Top left): Structural model of tRNA-bound CtKti12NTD based on superimposition
with MjPSTKNTD (3ADB), r.m.s.d. = 3.8 A˚2. tRNASec is shown in grey and MjPSTKCTD in yellow. The 3′ end of the superimposed tRNASec reaches
to the active site of CtKti12NTD. Surface charge distribution of CtKti12NTD is shown in blue and red. Positively charged regions (blue) coincide with a
modelled contact surface with tRNASec. Color coding and scale are identical to Figure S5. (Bottom right): The close up of the model shows the proposed
tRNA interaction surface at the NTD, which is shown in light blue, acceptor stem of tRNASec is gray. Mutants with significantly downregulated ATPase
activity are shown in red, mutants with moderate ATPase properties in orange. Hydrolytic activity after mutating residues shown in green does not differ
significantly fromWTprotein. The gatekeepingR213 residue (asterisk) is shown in violet. (B) Analyses of hydrolytic properties of tRNA interaction surface
mutants using the malachite green assay. Calculated standard deviations are shown (n= 3). Color coding as in (A). (C) tRNA-independent ATP hydrolysis
of mutants within tRNA-interaction interface on the NTD using the malachite green assay. The results were normalized to the tRNASec-induced hydrolysis
of WT protein and calculated standard deviations are shown (n = 3). (D) Binding affinity of tRNA-interface mutants to the bulk yeast tRNA. Samples
were resolved on a 5% native PAGE. As a loading control, samples were also analyzed by denaturing SDS-PAGE stained with Coomassie. tRNA was
stained using SYBR-Gold.
K14A and T15A also conferred resistance indicating that
nucleotide hydrolysis is vital for Kti12 to support Elonga-
tor’s U34 modification function. Among the phenotypes of
mutants with moderately reduced U34 modification levels
(Figure 5A), resistance to zymocin and  -toxin was pro-
nounced in the D85A but weaker for the T15A/D85A mu-
tant and entirely absent from T16A cells (Figure 5B). The
phenotype of the latter is remarkable since the mcm5s2U
levels measured by LC–MS/MS are similar to D85A or
T15A/D85A mutants (Figure 5A). Of note, however, while
the ncm5U and mcm5U modification levels are comparable
between the T16A mutant and KTI12 wild-type cells, they
are significantly reduced in theD85A and T15A/D85Amu-
tants.
Therefore, we resorted to an alternative in vivo assay
(SUP4) that is diagnostic specifically for the mcm5U mod-
ification. SUP4 encodes a tRNA suppressor that decodes
ochre stop codons when its anticodon carries the Elongator
dependent mcm5U modification (4,68). Hence ochre muta-
tions in ade2–1 and can1–100 reporter genes are suppressed
by SUP4 in an Elongator dependent fashion resulting in
adenine prototrophy (growth on media lacking adenine)
and canavanine sensitivity (due to uptake of the toxic argi-
nine analog canavanine by restored expression of arginine
permease Can1) (4,68). As a consequence, mcm5U modi-
fication defects typical of elp3 and kti12 mutants abol-
ish SUP4 tRNA suppressor activity and cause adenine aux-
otrophy and canavanine resistance (Figure 5B). In the same
SUP4 assay, the K14A and T15A mutants with Elongator
defects show Kti12 loss-of-function phenotypes while the
T16A mutant behaves like wild-type confirming the toxin
assay data above and the importance ofKti12ATPase activ-
ity for Elongator’s U34 modification capacity (Figure 5B).
In contrast, the D85A and T15A/D85A mutants displayed
adenine auxotrophy but partial resistance toward canava-
nine. Intriguingly, the latter trait is intermediate between the
loss-of-function (kti12) and wild-type (Figure 5B). This
indicates that the can1–100 reporter appears to bemore sen-
sitive than ade2–1 to variations in the mcm5U34 levels. The
reduced mcm5U34 level in the D85A and T15A/D85A mu-
tants is sufficient to give some protection against canava-
nine likely by reduced permease levels but insufficient to
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Figure 5. Effect of ScKti12 mutants on Elongator’s U34 modification function. (A) Quantification of modified U34 nucleosides in tRNAs from yeast
strains carrying kti12 nucleotide binding pocket mutations. For each mutant, the relative levels of ncm5U, s2U, mcm5U andmcm5s2U are shown.Modified
nucleoside signals were normalized using the total uridine content A (modified U)/A (U), to allow comparison between different samples. ncm5, s2, mcm5
and mcm5s2 are highlighted in red within their chemical structure (top). (B) Zymocin-/ -toxin- and SUP4-based assays indicative for Elongator function
andU34 modification in vivo. WT (KTI12) and Elongator deficient elp3 and kti12 strains served as growth control for loss-of-functionmutants. Ten-fold
serial cell dilutions of the strains expressing Kti12 variants with the indicated mutations in the nucleotide binding pocket mutants (see A) were spotted
on SD glucose media with 60 g/ml canavanine, or 5% (v/v) zymocin, lacking adenine (- Ade) or containing 2 % (w/v) galactose (Gal:  -toxon) instead
of 2% (w/v) glucose (Glc:  -toxoff). For the  -toxin assay, strains were transformed with vector pLF16 expressing the  -toxin gene under the galactose
inducible GAL1 promoter (68) and cultivated for 3–4 days at 30◦C. (C) Kti12-Elongator interaction studies. Yeast strains co-expressing c-myc-tagged Elp1
and HA-tagged Kti12 variants were subjected to immunoprecipitation (IP) using anti-c-myc antibodies. IPs were examined by Western blotting with anti-
c-myc (to detect Elp1) and anti-HA antibodies (to detect co-immunoprecipitated Kti12). Western blots of the extracts prior to the IPs (Pre-IP) controlled
the input using anti-HA and anti-Cdc19 antibodies, to confirm similar levels of Kti12 and pyruvate kinase (Cdc19) in the different strains. (D) Purified
ScKti12 and ScElp1 interact in vitro. Full length GST-ScElp1 successfully bound ScKti12–6xHis in a concentration-dependent manner. Free GST was
used as a specificity control. For GST pull-down assay, gels were stained with Coomassie and respective proteins are labeled next to the gel.
provide enough ADE2 gene product to support prototro-
phy. The wild-type growth behavior with both readouts of
the T16A mutant (Figure 5B) is consistent with the wild-
type like mcm5U34 modifications levels measured by LC–
MS/MS (Figure 5A).
Thus, we explain the phenotypic variations between
T16A on the one hand and theD85A and T15A/D85Amu-
tants on the other, by differences in the measured ncm5U
and mcm5U modification levels and by differential sensi-
tivities between the ade2–1 and can1–100 reporters used to
diagnose U34 modification defects with SUP4. Apparently,
moderate reduction in mcm5s2U levels is not sufficient to
provide  -toxin/zymocin resistance in the T16A mutant in
contrast to D85A and T15A/D85A. We therefore propose
that the reduced levels of ncm5U andmcm5Umodifications
contribute to lower toxin sensitivity of the latter two mu-
tants. The SUP4 and zymocin/ -toxin assays show that the
loss-of-function phenotype of the T15Amutant is partially
rescued in the T15A/D85A double mutant. Genetic inter-
action observed between the residues T15 and D85 (analo-
gous to D129 in CtKti12) in the double mutant (Figure 5B)
is in agreement with our CtKti12 hydrolysis measurements
(Figure 3B), where lowATPase activity caused by the T15A
exchange was compensated in combination with theD129A
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substitution. In summary, our mass spectrometric and phe-
notypic data (Figure 5A and B) provide robust correlation
between decreased ATPase activity, reduced tRNA modifi-
cation levels and Elongator phenotypes and thus establish a
direct link between the ATP hydrolysis activity of Kti12 and
the U34 modification function of the Elongator complex
In addition, we have analyzed all structure guided mu-
tants in CtKti12 (Supplementary Figure S6A) and con-
firmed the importance of the equivalent residues for the
function of ScKti12 (Supplementary Figure S6B). Last but
not least, we have performed unbiased randomized muta-
genesis of Kti12 in yeast to identify additional functionally
important residues. Here, phenotypic studies highlight the
importance of the hydrophobic core of Kti12, its ATP bind-
ing pocket and the tRNA interacting interface on the NTD
for proper functioning of Kti12 in vivo (Supplementary Fig-
ure S6C).
Kti12 interacts directly with Elp1
As Kti12 was shown to interact with Elongator in vivo
(66,73,82), we were curious to see whether its ATPase ac-
tivity is necessary for the temporary recruitment to this
large macromolecular complex of ∼850 kDa (83). Strik-
ingly, our co-immunoprecipitation analyses show that both
wild-type and ATPase-deficient mutants of Kti12 interact
with Elongator at comparable levels in vivo (Figure 5C).
Hence, the ATPase activity of Kti12 neither constitutes a
regulatory step for its interaction with Elongator nor for
its binding to tRNA. These observations in yeast are fully
consistent with direct protein-protein interaction observed
between purified ScKti12 and full length ScElp1 in the ab-
sence of other co-factors in vitro (Figure 5D and Supple-
mentary Figure S6D). In addition, we show that neither the
presence of hydrolysable nucleotides nor non-hydrolysable
analogs affects this interaction in vitro (Supplementary Fig-
ure S6D). We and others (83,84) have recently determined
the architecture of the Elp123 subcomplex and the fully as-
sembled yeast Elongator complex. Hence, we were curious
to find out where Kti12 contacts Elongator and used indi-
vidually purified domains of Elp1 to map the interaction
site of Kti12 more precisely. Somewhat surprisingly, Kti12
specifically interacts with the first WD40 domain of Elp1
(Figure 6A), which seems spatially distant from the previ-
ously mapped phosphorylation sites in the CTD of Elp1
that are known to slightly affect Kti12 binding to Elonga-
tor in vivo (40). Nevertheless, our recent structural model of
Elp1 shows that these two regions, which are roughly 1,000
residues apart from each other in the primary sequence,
could in fact come into relatively close proximity in the as-
sembled Elongator complex (Figure 6B). Hence, to fully un-
derstand the underlying regulatory circuitry it remains to
be established where other regulatory factors (e.g. Hrr25
and Sit4) contact Elongator and how Kti12 could influence
their interactions. Nevertheless, we tested whether the inter-
action of Kti12 with Elp1 would have any effect on Kti12’s
ATPase activity. Notably, we observed a specific inhibition
of its tRNA-induced ATPase activity in the presence of all
Elp1 constructs that contain the firstWD40 domain (Figure
6C). Furthermore, we show that increasing amounts of the
interaction domain inhibit the ATPase activity in a strictly
concentration dependent fashion (Figure 6D). In summary,
we have identified a direct interaction between Elp1 and the
Kti12 protein, which is independent of ATP hydrolysis and
tRNA binding, but restricts the tRNA stimulated ATPase
activity of Elongator-bound Kti12.
The 3′CCA tail of tRNA is essential for the activation of eu-
karyotic Kti12s
Last but not least, we were curious if Kti12 might be
able to discriminate between different maturation stages
of tRNASec. Therefore, we produced a version of human
tRNASec lacking the 3′ CCA tail, which is added to tRNAs
by a nucleotidyl transferase. Next, we compared its ATPase
activation potential with tRNASer and mature tRNASec in
the established assays. Strikingly, tRNASec(w/o CCA) is not
able to induce the ATPase activity of neither ScKti12 nor
CtKti12. This data not only further confirm our model
of tRNA binding to the NTD (Figure 4A), but also raise
the possibility that Kti12 helps the Elongator complex to
discriminate between immature and mature tRNA species.
Furthermore, we were able to express and purify human full
lengthKti12 and confirmed its identical behavior and speci-
ficity (Figure 6E), showing that the here proposed mecha-
nism of activation is conserved between various eukaryotic
Kti12s. Notably, Kti12s from three different species process
ATP in the presence of non-aminoacylated tRNASec+CCA
approximately one hundred times faster than MjPSTK
(Figure 6E). This indicates that Kti12, in comparison to
PSTK,might not require a coupled amino acid at the tRNA
for its ATPase activation. Nevertheless, the activities of all
Kti12 and PSTK proteins have been tested at 37◦C (70) and
the observed variations might partially result from differ-
ences in the optimal temperature ranges for the individual
proteins, especially for proteins from thermophilic organ-
isms likeM. jannaschii or C. thermophilum.
DISCUSSION
Kti12 is the only known eukaryotic protein to share a
sequence-wide similarity with PSTK (43,44). Our initial
structural and functional analyses of Kti12 confirm this
notion and show that both proteins indeed consist of two
domains, an N-terminal ATPase domain and a C-terminal
high affinity tRNA-tethering domain.
We performed an in-depth gene distribution analysis of
confirmed Kti12 sequences, which revealed that Kti12 can
be found almost exclusively in eukaryotes, including land
plants and fungi that actually do not possess PSTK and
other components of the selenocysteine pathway (Figure
7A). Although putative Kti12-like sequences could be iden-
tified in two closely related archaeal subclades, a search in
all other archaeal species returned without any additional
hits. Whereas the enzymatically active Elp3 subunit and the
cm5U34 modification itself (85) are conserved in archaea,
the remaining five Elongator subunits are only found in
eukaryotes. After showing that the Elp1 subunit provides
the necessary docking platform on the eukaryotic Elonga-
tor complex, we suspect that the appearance of Kti12 is
coupled to the evolutionary occurrence and establishment
of a multi-subunit Elongator complex in eukaryotes and
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Figure 6. Functional studies of ScKti12 binding to Elongator. (A) The interaction site on ScElp1 was mapped using domains of ScElp1, namely, first
WD40 (aa 42–431), first and second WD40s (aa 1–734) and TRP (aa 919-1349). Interaction was observed only in case of constructs containing the first
WD40 domain. Inputs before the pull down are shown on the left and GST-tagged Elp1 proteins are shown below. Gels were stained with Coomassie and
respective proteins are labeled next to the gel. (B) A structural model of one lobe of the Elp123 subcomplex of Elongator built using integrative modelling
approach. Elp1 consists of two N-terminal WD40 domains (shades of orange), flexible linker region (gray) and a tetratricopeptide motif (TPR; teal) used
for dimerization of Elp1 molecules. Unstructured loop region (aa1175–1252) within Elp1 TRP is shown as dashed line. Red circles indicate presence of
multiple phosphorylation sites within the loop region. Surfaces of Elp2 (yellow) and Elp3 (pink) proteins are also shown. Kti12NTD (blue) is shown in a
vicinity of the identified interaction site. (C) Binding of ScElp1 to the ScKti12 inhibits tRNA-induced hydrolysis. 1 M ScElp1 protein was added to the
reaction mixture containing 1 M ScKti12. ScKti12 – first WD40 indicates ATP hydrolysis by a fusion protein, in which the first WD40 was linked to
the C-ter of ScKti12 using a flexible 5x(GS) linker. Results are normalized to the tRNASec-induced ATP hydrolysis in the absence of Elp1. Means and
calculated standard deviations are shown (n = 3). (D) The first WD40 domain of Elp1 inhibits tRNA-dependent ATP hydrolysis in a dose dependent
manner. Increasing amounts of first WD40 domain (orange squares) or TPR (tale circles) were added to the ATPase reaction, up to eight times greater
molar concentration of Elp1. Results are normalized to the tRNASec-induced ATP hydrolysis in the absence of Elp1. Error corridors represent standard
deviations (n = 3). (E) ATP hydrolysis of Kti12 is dependent on maturity of presented tRNA. Kti12 hydrolyses ATP in the presence of tRNASec with a
3′CCA (tRNASec, +CCA). Removal of 3′CCA from tRNASec (tRNASec, no CCA) resulted in almost complete diminishment of inducing properties of
tRNASec. ATP hydrolysis was assessed with the malachite green assay. kcat values were calculated based on the ATP hydrolysis after 4 h (data not shown).
Tested conditions resulted in following kcat values: kcat (ScKti12) = 5.85×10−3 ± 0.28×10−3 s−1; kcat (CtKti12) = 2.19×10-3 ± 0.05×10−3 s−1; kcat
(HsKti12) = 14.05×10−3 ± 0.10·10−3 s−1. PSTK from hyperthermophylic archaea exhibited lower kcat values upon induction by tRNASec, kcat(MjPSTK)
= 2.9×10−5 ± 0.3×10−5 s−1 (Sherrer et al., 2008b). Calculated means and standard deviations are shown (n = 3).
more precisely Elp1. Strikingly, animals, including mam-
mals and humans, possess both Kti12 and PSTK. Accord-
ing to publicly available tissue expression databases (86,87),
human and murine Kti12 and PSTK mRNAs and proteins
are ubiquitously expressed in different tissues, excluding the
possibility of cell type specific production of only one of
the proteins at a time. Here we demonstrate that the two
proteins get activated by tRNASec and therefore it remains
to be shown if their structural and functional similarities
may lead to cross activation and/or functional redundancy
in animals and specifically in humans.
In general, both proteins share multiple similarities, in-
cluding domain architecture and structure, tRNA bind-
ing properties, ATPase activities and downstream signaling
to posttranscriptional modification reactions (Figure 7B).
PSTK needs to specifically select for tRNA[Ser]Sec at the ini-
tial binding step to catalyze the production of tRNA[Sep]Sec
and at the same time avoid undesired phosphorylation
of tRNA[Ser]Ser. Kti12 binds various uncharged tRNAs,
strongly suggesting that Kti12 does not require high speci-
ficity and is not likely to carry out specific kinase reactions
on these tRNAs.Nevertheless,Kti12 is specifically activated
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Figure 7. A comparison of Kti12 and PSTK analogs. (A) Schematic
overview of the phylogenetic analyses of PSTK and Kti12 distribution.
With the exception of bacteria, which use SelA protein for selenocysteine
synthesis, PSTK appears together with a tRNASec in archaea and ani-
malia. Plantae and fungi are missing both PSTK as well as tRNASec. Kti12
can be foundwithin all eukaryotic lineages, which is also true for its interac-
tion partner Elp1. (B) PSTK andKti12 architectures are very similar. Both
proteins bind tRNA, however, unlike PSTK, Kti12 is capable of binding
to bulk yeast tRNA. Both PSTK and Kti12 utilize tRNA binding for in-
duction of ATP hydrolysis. PSTK transfers gamma phosphate from ATP
to tRNA[Ser]Sec generating tRNA[Sep]Sec, which is further used as a sub-
strate by SepSecS, a tetrameric enzyme capable of using selenophosphate
as a selenium donor for formation of Sec-tRNASec. Two catalytically ac-
tive subunits of human SepSecS are shown in light green while catalytically
inactive subunits are dark green. In case of Kti12, ATP hydrolysis enables
cm5U34 modification in the anticodon of 11 tRNA species by the Elonga-
tor complex.
by tRNASec in vitro at an almost identical surface of the
NTD, which indicates a similar coupling of tRNA recog-
nition and triggering of ATPase activity.
It is worth emphasizing that the amino acid phosphory-
lated by PSTK and the cm5 modified U34 base are located
on opposite sides of the tRNA molecule, which make it
hard to imagine that the ATPase activity of Kti12 is directly
involved in the catalytic modification reaction of Elonga-
tor. Nonetheless, our data do show that the function of the
Kti12 protein is tightly connected to the tRNAmodification
activity of the Elongator complex. Strikingly, the PSTK
substrate tRNA[Ser]Sec carries U34 modifications (78,88). In
addition, opal (UGA) read-trough by a tRNA[Ser]Ser sup-
pressor in yeast (sup9e) has been shown to rely on the ac-
tivity of the Elongator complex (89). A strong activation of
Kti12 by tRNASec could be needed for the Elongator com-
plex to deal with this rather unusual tRNA species, which
was reported to have a longer acceptor stem, an extended
variable loop and different D- and T-arms in relation to
canonical tRNASer (74). The precise role of the tRNA in-
duced ATPase activity of Kti12 in the modification of other
tRNAs is unclear. We speculate that Kti12 might trigger
the recruitment or release of other regulatory factors of the
Elongator complex. For instance, Kti12 might allow the re-
cruitment of the Elongator kinase Hrr25 or the release of
the phosphatase Sit4 to promote phosphorylation of Elp1
or vice versa to promote dephosphorylation. Kti12 could
in principle employ its tRNA-induced ATP hydrolysis also
to directly phosphorylate Elongator upon tRNA binding,
but we neither detected any direct phosphorylation of Elp1
in vitro using purified proteins nor Kti12’s ATPase activity
seems to be functional in the proximity of Elp1. In addition,
it is worth mentioning that Kti12 might have additional or
alternative functions independent of Elongator (90).
Last but not least, both Elongator and Kti12 can bind
to free tRNA and the CTD of Elp1 is involved in tRNA
and Kti12 binding in vivo (7,40,91). To date it is not clear,
whether Kti12 could bind a tRNA molecule that is also
bound to the Elongator complex and whether PSTK can
bind to Elongator in a similar fashion as Kti12. Our data
show that the ATPase activity of Kti12, which is essential
for the tRNA modification activity of Elongator, does re-
quire the 3′CCA tail. This observation could indicate that
Kti12 acts as a gatekeeper for Elongator that allows only
tRNAs at a certain maturation stage to be modified by the
complex. Our data on Elp1-mediated inhibition of Kti12,
also indicates that the newly identified surface area of Kti12
that is activated by the tRNA 3′CCA tail might be covered
by the binding to Elp1. Though, in this scenario Elongator-
bound Kti12 might still interact with tRNA via its flexi-
ble C-terminus and it remains to be shown at which stage
the ATPase activity is required. In addition, we need to un-
derstand if binding of Kti12 to tRNAs or Elongator in-
duces similar rearrangements of the NTD and linker re-
gions as shown for PSTK (71). It is worth mentioning that
this mechanism is conserved among organisms that either
possess (human) or lack (fungi) the selenocysteine path-
ways. In summary, our complementary structural and func-
tional characterization of Kti12 indicates strong similari-
ties between the regulatory mechanisms of Elongator medi-
ated tRNA modifications and translational recoding of the
seleno-proteome in higher eukaryotes.
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